- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01170273
Vitamin D in Vulnerable Adults (VIVA-VA) (VIVA-VA)
October 28, 2016 updated by: VA Office of Research and Development
Vitamin D in Vulnerable Adults
Vitamin D insufficiency is a problem of growing concern, given its prevalence in older persons and the association of low vitamin D with multiple major health problems, including mobility and balance deterioration and falls, cardiovascular disease, diabetes, and certain cancers.
Sedentary persons are particularly vulnerable for these health problems and generally not adherent to prescribed physical activity.
This study will investigate if treatment with vitamin D will benefit physical performance in male veterans age 65 to 95.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
130
Phase
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Florida
-
Miami, Florida, United States, 33125
- VA Medical Center, Miami
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
65 years to 95 years (Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- male veterans
- 65 to 95 years of age
- independent
- sedentary
- vitamin D insufficiency
Exclusion Criteria:
- hypercalcemia
- renal failure
- living in a nursing home
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Placebo Comparator: Placebo Arm
placebo capsule
|
placebo tablet
|
|
Experimental: Cholecalciferol 4000 IU
cholecalciferol 4000 IU daily
|
cholecalciferol
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Short Physical Performance Battery Test Score
Time Frame: baseline and 9 months
|
The short physical performance battery (SPPB) examines 3 areas of lower extremity function: static balance test, gait speed test and getting in and out of a chair test.
The total SPPB score is the sum of the scores of the 3 components and can range from 0 to 12, with 0 reflecting severe limitations and 12 minimal or no limitations.
The ranges for each subscale are: balance (0-4), gait speed (0-4), sit-to-stand (0-4).
In all the subscales, 0 reflects worse outcome and 4 best outcome.
|
baseline and 9 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Silvina Levis-Dusseau, MD, VA Medical Center, Miami
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2010
Primary Completion (Actual)
June 1, 2014
Study Completion (Actual)
December 1, 2014
Study Registration Dates
First Submitted
July 22, 2010
First Submitted That Met QC Criteria
July 23, 2010
First Posted (Estimate)
July 27, 2010
Study Record Updates
Last Update Posted (Estimate)
December 21, 2016
Last Update Submitted That Met QC Criteria
October 28, 2016
Last Verified
October 1, 2016
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- F7574-R
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Frail Elderly
-
DSM Nutritional Products, Inc.CompletedFrail Elderly | Pre-frail ElderlyNetherlands
-
Maimonides Medical CenterCompletedElderly | Frail Elderly | Hospitalization | Geriatrics
-
Aalborg University HospitalUniversity of Copenhagen; Hvidovre University Hospital; Amager Hospital; Aalborg...Completed
-
University of SalamancaExcelentísimo Ayuntamiento de SalamancaCompleted
-
University of ManitobaTerminated
-
McMaster UniversityCanadian Frailty NetworkCompleted
-
Health Center of the City of JoensuuUnknown
-
Marmara UniversityEnrolling by invitationFrail ElderlyTurkey (Türkiye)
Clinical Trials on placebo
-
SamA Pharmaceutical Co., LtdUnknownAcute Bronchitis | Acute Upper Respiratory Tract InfectionKorea, Republic of
-
National Institute on Drug Abuse (NIDA)CompletedCannabis UseUnited States
-
AstraZenecaParexel; Spandauer Damm 130; 14050; Berlin, GermanyCompletedMale Subjects With Type II Diabetes (T2DM)Germany
-
AkesoNot yet recruitingAtopic DermatitisChina
-
Heptares Therapeutics LimitedCompletedPharmacokinetics | Safety IssuesUnited Kingdom
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited Kingdom, Netherlands
-
Shijiazhuang Yiling Pharmaceutical Co. LtdXuanwu Hospital, BeijingCompleted
-
GlaxoSmithKlineCompletedInfections, BacterialUnited States
-
Chong Kun Dang PharmaceuticalUnknownHypertension | DyslipidemiasKorea, Republic of